“Nanotechnology and micro-devices for the diagnosis and treatment of infectious diseases with emphasis on Covid-19: Novel products and high TRL prototypes in Greece”.
The Scientific Program Committee invites you to submit your abstract/s. Please carefully read the information outlined below.
Monday September 21 Abstract submissions close
Friday September 25 Speakers announcement
Thursday October 1 Webinar
ABSTRACT REVIEW CRITERIA
Novelty and Significance
High-ranking abstracts will address novel questions and present new
findings not previously reported.
Relevance and Interest
Abstracts should be of major relevance and interest to scientists in the fields of medical science and nanotechnology.
Methods should be scientifically sound and appropriate to answer the questions being asked. Data should be presented clearly with appropriate statistical analysis.
Conclusions should be well substantiated and appropriate to the data presented.
- If the submitted abstract (research) was funded by a commercial entity, this MUST be declared.
- You must use the guidelines attached in order to prepare your abstract accordingly.
- Abstracts need to be submitted via email to firstname.lastname@example.org
If you have any questions please email email@example.com or call +30 210 3607690